NPRA Import Licence for Pharmaceutical Products: Requirements, Process, and Renewal

The NPRA Import Licence is the operational permit that turns a Product Registration Holder into an importer. Without it, a registered pharmaceutical product cannot legally enter the country in commercial quantity, regardless of how the MAL number is documented. With it, the company in whose name the licence is issued takes on the responsibility for the product from the moment it leaves the overseas manufacturer to the moment it sits in the Malaysian warehouse, including the insurable interest in the cargo during transit.

This is the licence that every private-sector Sdn Bhd importer-distributor in Malaysia needs to hold or to be appointed against, and it is the single regulatory artefact that anchors the cargo insurance conversation for pharmaceutical imports. The Guideline on Application of Manufacturer's, Import and Wholesaler's Licenses for Registered Products (3rd Edition, March 2025), issued by the National Pharmaceutical Regulatory Agency under the Ministry of Health, is the authoritative reference for everything that follows.

Key Facts: NPRA Import Licence for Pharmaceutical Products

What is the NPRA Import Licence? It is a licence issued under the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984, authorising a company registered in Malaysia to import and to sell by wholesale or supply registered pharmaceutical products from its premises. The Director of Pharmaceutical Services, Ministry of Health is the issuing authority.

Who can apply for the Import Licence? A company registered in Malaysia that is either the Product Registration Holder (PRH) for the products to be imported, or has been appointed by the PRH as the importer. The imported products themselves must be registered with the Drug Control Authority (DCA), Ministry of Health.

What is the processing fee and approval timeline? The Import Licence processing fee is RM 500.00 per application, non-refundable, paid online through QUEST3+ (NPRA, 2025). The NPRA Client Charter timeline for complete applications is four working days from a complete submission to approval.

How long is the licence valid? Each Import Licence is valid for one year, expiring on 31 December of the year of issue, or such period as specified in the licence itself. Renewal applications must be submitted on or before the date announced by NPRA, or before the licence expires.

What does the licence not permit? Every licence is tied to the specific company name and address on the licence document. It is not transferable to another person or company, and any change of company name, premises, or store information requires a fresh application rather than an amendment.

Where does insurable interest on imported pharmaceutical cargo sit? With the Import Licence holder. Once risk transfers to the importer under the contractual Incoterm (CIF and CIP at origin port; FOB and CFR on board the vessel), the importer carries the financial exposure to physical loss or damage to the cargo, which is the legal basis for placing marine cargo insurance under Institute Cargo Clauses.

For the full pharmaceutical imports cargo insurance framework, see the Pharmaceutical & Medical Devices Cargo Insurance industry page and the pharmaceutical imports cargo insurance cluster hub.

Resource: Cargo Insurance Coverage Audit

Take the 9-question Cargo Insurance Coverage Audit to score your current pharmaceutical cargo programme against the industry baseline. Free, no signup wall.

What the Import Licence Is and Who It Covers

The Import Licence sits inside a three-licence regime that the NPRA administers for activities involving DCA-registered products. The Manufacturer's Licence covers companies that manufacture registered products in Malaysia. The Import Licence covers companies that bring those registered products into Malaysia. The Wholesaler's Licence covers companies that supply or sell those registered products by wholesale within Malaysia. A single company may hold one, two, or all three licences depending on the scope of its activities.

For private-sector pharmaceutical importer-distributors, the Import Licence is the headline document. It is paired in practice with a Wholesaler's Licence in nearly every case, because importing a registered product without the ability to supply it by wholesale is commercially unusual. Both licences run on the same annual cycle, are applied for through the same QUEST3+ system, and share most of the same pre-conditions.

The licence is product-specific. It does not authorise importation of any registered pharmaceutical product in the abstract; it authorises importation of a defined list of registered products held by the licence holder. The List of Products is annexed to the licence at issue. Adding new products to the list requires a separate application through QUEST3+, supported by a copy of the current Import Licence and a copy of the DCA approval for the new product.

The Six Pre-Conditions Before You Can Apply

The NPRA Guideline sets out six pre-conditions that a company must satisfy before it can lodge an Import Licence application. All six need to be in place; missing any one is a basis for the application not to proceed.

The PRH-versus-appointed-importer distinction in pre-condition two is the one that most often trips up new entrants. A Malaysian Sdn Bhd may want to import a product registered overseas, but the MAL number sits with whichever entity is documented as the Product Registration Holder at the time of registration. If the importer is not the PRH, an appointment letter from the PRH must be in place before the Import Licence application is lodged, and the appointment must specifically cover the products on the licence list.

The licence holder carries the insurable interest on each shipment, which is why placement decisions sit with the NPRA-licenced importer. For ongoing programmes, Marine Cargo Open Cover is the working structure. For the industry view, see Pharmaceutical & Medical Devices Cargo Insurance.

The QUEST3+ Application Process

The full Import Licence application is lodged online through the NPRA QUEST3+ portal at quest3plus.bpfk.gov.my. Manual applications are reserved for government agencies; private-sector applicants use QUEST3+ exclusively. First-time users must register as a QUEST3+ User; the registration process is documented on the NPRA Official Portal.

Documents to Upload

The supporting documents listed in the NPRA Guideline for a new Import Licence application are:

• A copy of the Company Registration Certificate (SSM registration).
• A copy of the licence holder's Identity Card, or Passport for non-Malaysians.
• A copy of the valid Business License from the Local Authority for business premises.
• A copy of the valid Business License from the Local Authority for any store premises.
• A copy of the valid Type A Poison Licence (Wholesale) where Scheduled Poison products are involved. The identity card or passport copy and the Type A Poison Licence must reference the same person.
• A completed Lampiran B form, in line with the 2025 NPRA improvement notification on the licence issuance process.

Responsible Persons

The company must appoint two responsible persons related to the licence application. One of the two must be a Malaysian and must be contactable by NPRA for correspondence through the QUEST3+ system.

Processing Fee and Timeline

The processing fee is RM 500 per application for an Import Licence, paid online through QUEST3+, and is not refundable regardless of the outcome. Under the NPRA Client Charter, complete applications are approved within four working days. Incomplete applications, or applications with unsatisfactory supporting documents, are returned through the QUEST3+ correspondence channel, and the application is not progressed until the deficiency is resolved.

Validity, Annual Cycle, and Renewal

Every Import Licence is valid for one year. The standard expiry is 31 December of the year of issue, or such other period as specified in the licence itself. This sets up an annual renewal cycle that aligns with the calendar year and means most importer-distributors are renewing in late Q4 each year.

For licence renewal applications, the NPRA Guideline narrows the documentation requirement materially. Only the supporting documents covering business licences (premises and store) and the Type A Poison Licence (Wholesale) where applicable, together with a copy of the previous Import Licence, need to be re-submitted. The Company Registration Certificate and the licence holder's identity document do not need to be re-uploaded for renewal.

The timing rule is clear: renewal applications must be submitted on or before the date announced by NPRA for that cycle, or before the licence expires. Letting the licence lapse without renewing on time is treated as not renewing, which triggers a new licence application under the change-of-information rules below rather than a renewal.

Changes That Trigger a New Application Rather Than an Amendment

The NPRA Guideline lists specific changes that require the company to apply for a fresh Import Licence, not to amend the existing one.

For importers handling cold chain product, the TTSP rule deserves particular attention. Any change to how the company stores time and temperature-sensitive products after the most recent NPRA inspection, including changes in store equipment or store address, triggers a new licence application rather than an in-place amendment. This is the regulatory hook that connects the licensing regime to the GDP regime that follows.

Adding Products to an Existing Licence

Where the company already holds a current Import Licence and wants to bring in a newly registered product, or where an existing registered product on the licence has changed name or manufacturer, the route is an Additional Product List application through QUEST3+ rather than a new licence. The supporting documents are a copy of the current Import Licence and a copy of the DCA approval letter for the new or amended product. The licence itself is not re-issued; the annexed List of Products is updated.

The Insurance Bridge: Insurable Interest at the Point of Licence

The Import Licence is more than a regulatory artefact. It is the legal anchor for the importer's commercial position in the cargo, and that position carries the insurable interest in the goods during transit.

The mechanics are straightforward. Once the contractual Incoterm transfers risk from the overseas seller to the Malaysian importer (at the origin port under CIF or CIP, on board the vessel at the origin port under FOB or CFR per the Incoterms 2020 risk transfer rules published by the International Chamber of Commerce), the importer carries the economic exposure to physical loss or damage to the cargo. That exposure is what the cargo insurance policy responds to, and the licence holder is the party that the policy names. For the full framework of who is responsible for cargo insurance under each Incoterm, see Incoterms 2020 cargo insurance responsibility.

This is the asymmetry that several Malaysian importer-distributors find at claim rather than at placement: the overseas supplier may have arranged a CIF shipment with a basic ICC (C) certificate, but the cargo is travelling at the importer's risk for most of the journey, and the importer is the party who bears the financial loss if the cargo arrives damaged or temperature-compromised. The Import Licence holder is the party who can recover under the policy, but only if the policy is structured to match the actual cargo profile, which is rarely the case with a generic CIF certificate.

For cold chain pharmaceutical imports specifically, ICC (A) 2009 is the practical minimum, with a temperature deviation endorsement layered in, GDP-aligned documentation conditions agreed at placement, and the per-shipment value declared at full replacement cost rather than invoice value for biologics. The open cover marine cargo insurance product is the standard placement structure for importers with regular shipment cadence; for high-value biologics consignments, see specialist and high-value transit insurance, and for one-off movements (including controlled substances under specific NPRA permits), see single shipment marine cargo insurance. For deeper detail on the named gaps in standard ICC (A) for pharmaceutical cargo, see the cluster article on pharmaceutical imports cargo insurance cluster hub.

Holding an NPRA Import Licence means holding the cargo risk.

Voyage arranges specialist marine cargo insurance for NPRA-licensed pharmaceutical importers, with temperature deviation, GDP-aligned documentation, and controlled substances handling negotiated at placement. Request a coverage review at voyagecover.com/#contact-form or WhatsApp Kevin at +60 19 990 2450.

How the Import Licence Interacts with Other Malaysian Trade Regimes

For most pharmaceutical imports, the NPRA Import Licence is the headline document, but it sits alongside a small number of other regulatory artefacts.

The Drug Control Authority's product registration (MAL number) is the upstream requirement. Without a valid MAL number, the product cannot be added to the Import Licence list. MAL numbers carry a registration category suffix in the format "MAL" plus eight digits plus an alphabet character indicating the category of registration.

The Royal Malaysian Customs Department (JKDM) handles customs clearance and import duty assessment under the Customs Act 1967 and the uCustoms system. Pharmaceutical products carry tariff treatment under the appropriate HS Code, and the import value declared to customs is the basis for duty calculation. The customs declared value and the insured value should align, with the standard 10 percent uplift over CIF or CIP value following UCP 600 Article 28 for Letter of Credit transactions.

For controlled substances under the Dangerous Drugs Act 1952 and Scheduled Poisons under the Poisons Act 1952, additional permits sit on top of the NPRA Import Licence. The permit regime, the Pharmacist Type A Poison Licence requirement, and the storage and handling conditions are covered in the related cluster article on importing controlled substances and scheduled poisons. Some categories of pharmaceutical product also fall within the wider restricted goods import licence regime administered by other Malaysian agencies.

Frequently Asked Questions

Can an overseas pharmaceutical principal hold the NPRA Import Licence directly?

No. The Import Licence applicant must be a company registered in Malaysia. Overseas principals typically appoint a Malaysian Sdn Bhd, either as the Product Registration Holder or as a separate appointed importer, to hold the Import Licence on their behalf.

What is the difference between the Import Licence and the MAL registration number?

The MAL number is the product registration issued by the Drug Control Authority under the Control of Drugs and Cosmetics Regulations 1984. It identifies a specific pharmaceutical product as registered in Malaysia. The Import Licence is the operational licence issued to a specific company under the same regulations, authorising that company to import that registered product. A product can only be added to an Import Licence list if it holds a current MAL number.

How long does it take to get an NPRA Import Licence approved?

Under the NPRA Client Charter, complete applications are approved within four working days. Incomplete or unsatisfactory applications are returned through the QUEST3+ correspondence channel; the four-day clock effectively resets once a complete and satisfactory application is back in NPRA's queue. Premises inspection scheduling can affect the practical timeline beyond the four-day Client Charter window.

How much does the Import Licence application cost?

The Import Licence processing fee is RM 500.00 per application, paid online through QUEST3+, and is not refundable regardless of the outcome of the application. Renewal applications attract the same fee.

Does the Import Licence cover Scheduled Poisons automatically?

No. Handling Scheduled Poisons under the Poisons Act 1952 requires the company to appoint a pharmacist who holds a valid Type A Poison Licence (Wholesale), and the same person who holds the Identity Card or Passport on the Import Licence application must hold the Type A Poison Licence. Adding or removing a Scheduled Poison category from the licence triggers a new licence application rather than an amendment.

What happens if the Import Licence is not renewed on time?

Failure to renew the licence before it expires is treated as not renewing, which means a fresh Import Licence application is required rather than a renewal. The company is also unable to import registered product in the meantime, because the operational licence is what authorises the activity.

Where does insurable interest on the imported cargo sit?

With the Import Licence holder, once risk has transferred under the contractual Incoterm. Under Incoterms 2020 CIF and CIP, risk transfers at the origin port. Under FOB and CFR, transit risk sits with the buyer once the goods are on board the vessel at the origin port, with the seller retaining pre-loading exposure. The Import Licence holder is the party named on the cargo insurance policy and the party who can claim under it, subject to policy terms and conditions.

Can I use a single Import Licence to cover both my Klang and Penang stores?

Each store address must be listed on the licence, and stores must generally be in the same state as the business premises. The NPRA Guideline makes an explicit exception for Selangor and the Federal Territory of Kuala Lumpur and Putrajaya, which are treated together. Adding a store in a different state from the business premises typically requires a separate licence structure; confirm the specific configuration with NPRA before lodging the application.

Voyage Conclusion

The NPRA Import Licence is the regulatory document that anchors the pharmaceutical import relationship. Six pre-conditions, a four-working-day Client Charter, an RM 500 fee, an annual cycle to 31 December, and a tightly controlled list of changes that trigger a new licence rather than an amendment. The full guideline is publicly available from NPRA as the 3rd Edition March 2025 release.

What the licence does not arrange is the cargo insurance. Holding the Import Licence means holding the insurable interest on the cargo from the moment risk transfers under the Incoterm.

Talk to Voyage about Marine Cargo Open Cover for NPRA-licenced pharmaceutical importers carrying full insurable interest from origin port to GDP-certified warehouse. For high-value transits, Specialist High-Value Transit Insurance applies. For the industry view, see Pharmaceutical & Medical Devices Cargo Insurance. WhatsApp +60 19 990 2450 or use the contact form.

Take the Cargo Insurance Coverage Audit

Score your pharmaceutical cargo programme: Cargo Insurance Coverage Audit. Free, no signup wall.

Related in the pharmaceutical cluster: pharmaceutical imports cargo insurance cluster hub, importing controlled drugs into Malaysia, GDP pharmaceutical distribution in Malaysia, plus the broader foundational guides: Institute Cargo Clauses and LC insurance certificate requirements.

Disclaimer: This article provides general guidance on the NPRA Import Licence for pharmaceutical products as of May 2026. Licensing requirements, fees, and procedures are administered by the National Pharmaceutical Regulatory Agency under the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984. Specific application requirements may change; confirm current requirements with NPRA at npra.gov.my before lodging an application.

Coverage terms, conditions, and availability vary by insurer, policy, and jurisdiction. Always review your specific policy wording and consult a qualified insurance or legal professional before making coverage decisions.